Iovance Biotherapeutics
IOVA
IOVA
122 hedge funds and large institutions have $1.31B invested in Iovance Biotherapeutics in 2018 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 52 increasing their positions, 18 reducing their positions, and 7 closing their positions.
Holders
122
Holders Change
+35
Holders Change %
+40.23%
% of All Funds
2.8%
Holding in Top 10
9
Holding in Top 10 Change
+7
Holding in Top 10 Change %
+350%
% of All Funds
0.21%
New
43
Increased
52
Reduced
18
Closed
7
Calls
$7.71M
Puts
$1.57M
Net Calls
+$6.14M
Net Calls Change
+$5.55M
Top Buyers
Top Sellers
1 |
BC
1
Broadfin Capital
New York
|
$15.4M |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$8.62M |
3 |
3
Axa
Paris,
France
|
$1.43M |
4 |
PM
4
Prosight Management
Dallas,
Texas
|
$3.55M |
5 |
5
Millennium Management
New York
|
$8.63M |